The Role and Clinical Implications of the Retinoblastoma (RB)-E2F Pathway in Gastric Cancer

Gastric cancer is the most common malignant tumor in the digestive tract, with very high morbidity and mortality in developing countries. The pathogenesis of gastric cancer is a complex biological process mediated by abnormal regulation of proto-oncogenes and tumor suppressor genes. Although there h...

Full description

Bibliographic Details
Main Authors: Tianyi Wu, Lizhao Wu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.655630/full
_version_ 1819106586931494912
author Tianyi Wu
Lizhao Wu
author_facet Tianyi Wu
Lizhao Wu
author_sort Tianyi Wu
collection DOAJ
description Gastric cancer is the most common malignant tumor in the digestive tract, with very high morbidity and mortality in developing countries. The pathogenesis of gastric cancer is a complex biological process mediated by abnormal regulation of proto-oncogenes and tumor suppressor genes. Although there have been some in-depth studies on gastric cancer at the molecular level, the specific mechanism has not been fully elucidated. RB family proteins (including RB, p130, and p107) are involved in cell cycle regulation, a process that largely depends on members of the E2F gene family that encode transcriptional activators and repressors. In gastric cancer, inactivation of the RB-E2F pathway serves as a core transcriptional mechanism that drives cell cycle progression, and is regulated by cyclins, cyclin-dependent kinases, cyclin-dependent kinase inhibitors, p53, Helicobacter pylori and some other upstream molecules. The E2F proteins are encoded by eight genes (i.e. E2F1 to E2F8), each of which may play a specific role in gastric cancer. Interestingly, a single E2F such as E2F1 can activate or repress transcription, and enhance or inhibit cell proliferation, depending on the cell environment. Thus, the function of the E2F transcription factor family is very complex and needs further exploration. Importantly, the presence of H. pylori in stomach mucosa may affect the RB and p53 tumor suppressor systems, thereby promoting the occurrence of gastric cancer. This review aims to summarize recent research progress on important roles of the complex RB-E2F signaling network in the development and effective treatment of gastric cancer.
first_indexed 2024-12-22T02:40:30Z
format Article
id doaj.art-beea7f4da83a43ec9ed9274feb3dc93c
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-22T02:40:30Z
publishDate 2021-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-beea7f4da83a43ec9ed9274feb3dc93c2022-12-21T18:41:40ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-05-011110.3389/fonc.2021.655630655630The Role and Clinical Implications of the Retinoblastoma (RB)-E2F Pathway in Gastric CancerTianyi WuLizhao WuGastric cancer is the most common malignant tumor in the digestive tract, with very high morbidity and mortality in developing countries. The pathogenesis of gastric cancer is a complex biological process mediated by abnormal regulation of proto-oncogenes and tumor suppressor genes. Although there have been some in-depth studies on gastric cancer at the molecular level, the specific mechanism has not been fully elucidated. RB family proteins (including RB, p130, and p107) are involved in cell cycle regulation, a process that largely depends on members of the E2F gene family that encode transcriptional activators and repressors. In gastric cancer, inactivation of the RB-E2F pathway serves as a core transcriptional mechanism that drives cell cycle progression, and is regulated by cyclins, cyclin-dependent kinases, cyclin-dependent kinase inhibitors, p53, Helicobacter pylori and some other upstream molecules. The E2F proteins are encoded by eight genes (i.e. E2F1 to E2F8), each of which may play a specific role in gastric cancer. Interestingly, a single E2F such as E2F1 can activate or repress transcription, and enhance or inhibit cell proliferation, depending on the cell environment. Thus, the function of the E2F transcription factor family is very complex and needs further exploration. Importantly, the presence of H. pylori in stomach mucosa may affect the RB and p53 tumor suppressor systems, thereby promoting the occurrence of gastric cancer. This review aims to summarize recent research progress on important roles of the complex RB-E2F signaling network in the development and effective treatment of gastric cancer.https://www.frontiersin.org/articles/10.3389/fonc.2021.655630/fullgastric cancerRB-E2F pathwaypocket proteinE2F familyHelicobacter pylorip53
spellingShingle Tianyi Wu
Lizhao Wu
The Role and Clinical Implications of the Retinoblastoma (RB)-E2F Pathway in Gastric Cancer
Frontiers in Oncology
gastric cancer
RB-E2F pathway
pocket protein
E2F family
Helicobacter pylori
p53
title The Role and Clinical Implications of the Retinoblastoma (RB)-E2F Pathway in Gastric Cancer
title_full The Role and Clinical Implications of the Retinoblastoma (RB)-E2F Pathway in Gastric Cancer
title_fullStr The Role and Clinical Implications of the Retinoblastoma (RB)-E2F Pathway in Gastric Cancer
title_full_unstemmed The Role and Clinical Implications of the Retinoblastoma (RB)-E2F Pathway in Gastric Cancer
title_short The Role and Clinical Implications of the Retinoblastoma (RB)-E2F Pathway in Gastric Cancer
title_sort role and clinical implications of the retinoblastoma rb e2f pathway in gastric cancer
topic gastric cancer
RB-E2F pathway
pocket protein
E2F family
Helicobacter pylori
p53
url https://www.frontiersin.org/articles/10.3389/fonc.2021.655630/full
work_keys_str_mv AT tianyiwu theroleandclinicalimplicationsoftheretinoblastomarbe2fpathwayingastriccancer
AT lizhaowu theroleandclinicalimplicationsoftheretinoblastomarbe2fpathwayingastriccancer
AT tianyiwu roleandclinicalimplicationsoftheretinoblastomarbe2fpathwayingastriccancer
AT lizhaowu roleandclinicalimplicationsoftheretinoblastomarbe2fpathwayingastriccancer